WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

EU-funded study investigates kidney regeneration potential

Details
Research
13 April 2010
A paper published in The Lancet journal, as part of a series on renal medicine, has questioned if kidney regeneration may be possible in human beings as it is in fish and other lower vertebrates.
Read more ...

Orphan Drugs to Create Paradigm Shift in the Pharmaceutical Industry

Details
Research
09 April 2010
The economic recovery process has proved difficult for the pharmaceutical industry. Factors like patent expiry, dry pipeline, and strict approval guidelines, have slowed down the attractive drug discovery and industry growth. Coupled with an investment risk in new therapy or molecules, this creates a challenge for the industry to overcome.
Read more ...

Two Compounds Discovered that Pave the Way for New Class of AIDS Drug

Details
Research
26 March 2010
According to the World Health Organization, about 33 million people currently live with HIV infections. Several drugs used to treat AIDS inhibit this HIV protease target, but drug-resistant mutants that impede the effectiveness of these drugs keep appearing and getting worse.
Read more ...

Electronic Clinical Decision Support for Middle Eastern Hospitals

Details
Research
11 March 2010
First DataBankHospitals in the Middle East are set to benefit from sophisticated electronic clinical decision support following the commercial agreement between First DataBank International (FDB International) and GE Healthcare (GE).
Read more ...

Google Announces Public Data Explorer

Details
Research
09 March 2010
Google announces an addition to Google Labs - the Public Data Explorer. The purpose of the new tool, Google says on the new lab's page, "The Google Public Data Explorer makes large datasets easy to explore, visualize and communicate.
Read more ...

MitoTarget Launches New Online Resource for Physicians and Sufferers from Rare Illness ALS

Details
Research
09 March 2010
Trophos, the pharmaceutical company specialising in therapies for orphan diseases including ALS (also known as Lou Gehrig's disease), announces, on behalf of the MitoTarget consortium, the launch of MitoTarget Online. The multilingual web-based resource aims to be the first point of call for all of those affected by ALS.
Read more ...

EU-funded researchers sequence human gut microbe genome

Details
Research
08 March 2010
EU-funded researchers have sequenced the genome of the community of microbes that lives in our guts. The study sheds new light on the influence of these microbes on our health and could lead to the development of new treatments and diagnostic tests for a variety of diseases.
Read more ...

More Pharma News ...

  1. Physicians Will Expand Range of Mobile Activities to Include Administrative and Patient Care Tasks
  2. Funds Boost Research into Causes, Interventions for Age-Related Cognitive Decline
  3. Powerful Universal Search Engine Makes Scientific Research Easy to Find
  4. Breakthrough may lead to anti-stroke vaccine
  5. The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels
  6. European Physician Adoption of Advanced Mobile Activities is Increasing
  7. Manhattan Research Releases New Research on DTC's Impact on Pharma Website Visitation
  • Start
  • Prev
  • 277
  • 278
  • 279
  • 280
  • 281
  • 282
  • 283
  • 284
  • 285
  • 286
  • Next
  • End
Tahmeena

Business & Industry

  • Pfizer reports record full-year 2022 results
  • AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries

Research & Development

  • Scientists pinpoint protein that helps cancer-causing viruses evade immune response
  • Transforming the way cancer vaccines are designed and made
  • Antidepressants used for chronic pain on the rise, but are they effective?
  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research
  4. Scientists pinpoint protein that helps cancer-causing viruses evade immune response

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.